RENAL FAILURE, HEPATIC FAILURE, AND GASTROINTESTINAL HEMORRHAGE
See full prescribing information for complete boxed warning.
- TRADE NAMES: Exjade (Novartis); Jadenu (Novartis)
- INDICATIONS: Chronic iron overload due to blood transfusions and in non-transfuson dependent thalassemia syndromes
- CLASS: Chelator, iron
- HALF-LIFE: 8–16 hours
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Alfuzosin, Aluminum-containing antacids, Ambrisentan, Aprepitant, Cabazitaxel, Cholestyramine, Cilostazol, Colesevelam, Colestipol, Conivaptan, Dabigatran, Darunavir, Dasatinib, Delavirdine, Docetaxel, Efavirenz, Enalapril, Estradiol, Eszopiclone, Fesoterodine, Gefitinib, Indinavir, Ixabepilone, Lapatinib, Lurasidone, Maraviroc, Pazopanib, Phenobarbital, Phenytoin, Pioglitazone, Repaglinide, Rifampin, Ritonavir, Sildenafil, Telithromycin, Theophylline, Tiagabine, Tipranavir, Trimethoprim, Ulipristal
- See adverse reactions attributed to class:
Please login to view the rest of this drug profile.
Page last updated 05/23/2025
